CA
NZ
UK
AU
IND
US
EZCORP Inc. Chief Operations Admin Officer Lucy Hernandez filed a Form 4 on November 12, 2026, disclosing the acquisition of 5,040 Restricted Stock Units on November 10, 2026, tied to Class A Non-Voting Common Stock.
DuPont announced a collaboration with Microsoft and NobleAI on November 12, 2026, aimed at expanding access to AI tools, including machine learning, to help its scientists and engineers accelerate innovation and reduce cycle times for delivering customer solutions.
Adage Capital Management, L.P., together with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, reporting beneficial ownership of 4,190,023 shares of common stock in Camp4 Therapeutics Corporation, a Delaware-incorporated biotherapeutics company headquartered in Watertown, Massachusetts.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of shares in Xilio Therapeutics, Inc. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of Class A Ordinary Shares of AMR Resources Acquisition Corp. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of 1,000,000 shares of Korro Bio, Inc. common stock as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, disclosing beneficial ownership of 1,800,000 Class A Ordinary Shares of Live Oak Acquisition Corp. VI as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC disclosing a 7.86% beneficial ownership position in Ares Acquisition Corp III's Class A Ordinary Shares, with a triggering event date of September 30, 2026.
Adage Capital Management, L.P. filed an amended Schedule 13G with the SEC on November 12, 2026, disclosing a beneficial ownership position in Opus Genetics, Inc. common stock as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed an amended Schedule 13G with the SEC on November 12, 2026, disclosing a 5.93% beneficial ownership position in Equillium, Inc. as of September 30, 2026.
Please wait processing your request...